Astra Zeneca

All the email addresses for astrazeneca.com

{first}.{last}@astrazeneca.com
1,766 email addresses
http://drugs.com/clinical_trials/new-data-show-investigational-compound-dapagliflozin-demonstrated-significant-reductions-blood-13826.html June 6, 2015
http://phrma.org/news-media/related-resources/member-companies April 4, 2015
http://astrazeneca-us.com/media/press-releases/2014/us-fda-approves-bydureon-pen-20140303.html May 5, 2017
http://astrazeneca-us.com/media/press-releases/2014/us-fda-approves-orphan-drug-myalept-20140225.html July 7, 2017
http://astrazeneca-us.com/media/press-releases/2014/brilinta-preferred-over-clopidogrel-20141006.html May 5, 2017
http://businesswire.com/news/home/20121114007283/fr May 5, 2015
http://astrazeneca-us.com/media/press-releases/2015/us-fda-approves-expanded-indication-for-brilinta-20150903.html June 6, 2017
http://free-email-address-importer.blogspot.rs/2015/09/3-email-address-for-marketing.html June 6, 2016
http://free-email-address-importer.blogspot.in/2015/09/3-email-address-for-marketing.html June 6, 2016
http://astrazeneca-us.com/media/press-releases/2014/astrazeneca-announces-progress-on-global-parthenon-20140317.html May 5, 2017
http://clinicaspace.com/news/eu-oks-bristol-myers-squibb-company-astrazeneca/279824/source=yesterdaysmostpopular January 1, 2015
http://businesswire.com/news/home/20121114006517/en/2783591/forxiga%E2%84%A2-dapagliflozin-first-in-class-sglt2-works-independently-insulin January 1, 2015
http://news.bms.com/press-release/rd-news/forxiga-dapagliflozin-first-class-sglt2-works-independently-insulin-now-approv&t=634886619666370272 April 4, 2015
http://biospace.com/news/eu-oks-bristol-myers-squibb-company-astrazeneca/279824/source=topbreaking January 1, 2015
http://phrma.org/node/321 March 3, 2016
http://biospace.com/News/eu-oks-bristol-myers-squibb-company-astrazeneca/279824/source=TopBreaking March 3, 2015
http://drugs.com/clinical_trials/pooled-analysis-showed-onglyza-saxagliptin-provided-improvements-key-measures-blood-sugar-control-14112.html January 1, 2015
http://m.news.bms.com/press-release/investigational-compound-news/pooled-analysis-showed-onglyza-saxagliptin-provided-impr April 4, 2016
http://businesswire.com/news/home/20140220005341/en/astrazeneca-patient-assistance-programs-million-patients-free January 1, 2015
http://biospace.com/news/astrazeneca-plc-bristol-myers-squibb-company/279824 May 5, 2016
http://fool.com/investing/businesswire/2012/11/14/forxiga-dapagliflozin-first-in-class-sglt2-that-wo.aspx March 3, 2016
http://fiercepharma.com/press-releases/forxiga-dapagliflozin-first-class-sglt2-works-independently-insulin-now-app-0 April 4, 2016
http://phrma.org/print/321 March 3, 2016
http://businesswire.com/news/home/20121114006517/en/2783595/forxiga%E2%84%A2-dapagliflozin-first-in-class-sglt2-works-independently-insulin January 1, 2015
http://news.bms.com/press-release/rd-news/forxiga-dapagliflozin-first-class-sglt2-works-independently-insulin-now-approv March 3, 2016
http://businesswire.com/news/home/20121114006517/en/2783592/forxiga%E2%84%A2-dapagliflozin-first-in-class-sglt2-works-independently-insulin January 1, 2015
http://free-email-address-importer.blogspot.hu/2015/09/3-email-address-for-marketing.html July 7, 2016
http://biospace.com/news/generous-astrazeneca-plc-provided-more-than-half-a/324634 July 7, 2017
http://biospace.com/news/eu-oks-bristol-myers-squibb-company-astrazeneca/279824 July 7, 2017
http://benzinga.com/pressreleases/12/11/b3090301/forxiga-dapagliflozin-first-in-class-sglt2-that-works-independently-of- July 7, 2017
http://astrazeneca-us.com/media/press-releases/2014/us-fda-approves-bydureon-pen-20140303.html December 12, 2016
http://astrazeneca-us.com/media/press-releases/2014/us-fda-approves-farxiga-tablets-20140113.html November 11, 2016
http://astrazeneca-us.com/media/press-releases/2014/us-fda-approves-orphan-drug-myalept-20140225.html November 11, 2016
http://businesswire.com/news/home/20140225006842/en/u.s.-fda-approves-orphan-drug-myalepttm-metreleptin January 1, 2015
http://businesswire.com/news/home/20140302005045/en/u.s.-fda-approves-bydureon%c2%ae-pen-exenatide-extended-release July 7, 2015
http://astrazeneca-us.com/media/press-releases/2014/astrazeneca-announces-progress-on-global-parthenon-20140317.html November 11, 2016
http://businesswire.com/news/home/20140302005045/en/u.s.-fda-approves-bydureon%C2%AE-pen-exenatide-extended-release February 2, 2015
http://news.bms.com/press-release/rd-news/astrazeneca-and-bristol-myers-squibb-announce-us-fda-approval-farxiga-dapaglif&t=635256032862460041 January 1, 2015
http://news.bms.com/press-release/rd-news/astrazeneca-and-bristol-myers-squibb-announce-us-fda-approval-farxiga-dapaglif&t=635248487269824722 April 4, 2015
http://news.bms.com/press-release/rd-news/us-fda-approves-farxiga-dapagliflozin-tablets-treatment-adult-patients-type-2-&t=635263692022369363 July 7, 2015
http://news.bms.com/press-release/rd-news/us-fda-approves-farxiga-dapagliflozin-tablets-treatment-adult-patients-type-2-&t=635256032862460041 January 1, 2015
http://businesswire.com/news/home/20140112005054/en/U.S.-FDA-Approves-Farxiga%E2%84%A2-Dapagliflozin-Tablets-Treatment May 5, 2015
http://news.bms.com/press-release/rd-news/us-fda-approves-farxiga-dapagliflozin-tablets-treatment-adult-patients-type-2-&t=635263697165377016 January 1, 2015
http://astrazeneca-us.com/media/press-releases/2014/us-fda-approves-bydureon-pen-20140303.html December 12, 2016
http://astrazeneca-us.com/media/press-releases/2014/us-fda-approves-farxiga-tablets-20140113.html November 11, 2016
http://astrazeneca-us.com/media/press-releases/2014/us-fda-approves-orphan-drug-myalept-20140225.html November 11, 2016
http://businesswire.com/news/home/20140302005045/en/u.s.-fda-approves-bydureon%c2%ae-pen-exenatide-extended-release July 7, 2015
http://businesswire.com/news/home/20140225006842/en/u.s.-fda-approves-orphan-drug-myalepttm-metreleptin January 1, 2015
http://businesswire.com/news/home/20140302005045/en/u.s.-fda-approves-bydureon%C2%AE-pen-exenatide-extended-release February 2, 2015
http://astrazeneca-us.com/media/press-releases/2014/astrazeneca-announces-progress-on-global-parthenon-20140317.html November 11, 2016
http://news.bms.com/press-release/rd-news/astrazeneca-and-bristol-myers-squibb-announce-us-fda-approval-farxiga-dapaglif&t=635256032862460041 January 1, 2015
http://businesswire.com/news/home/20140112005054/en/U.S.-FDA-Approves-Farxiga%E2%84%A2-Dapagliflozin-Tablets-Treatment May 5, 2015
http://news.bms.com/press-release/rd-news/astrazeneca-and-bristol-myers-squibb-announce-us-fda-approval-farxiga-dapaglif&t=635248487269824722 April 4, 2015
http://news.bms.com/press-release/rd-news/us-fda-approves-farxiga-dapagliflozin-tablets-treatment-adult-patients-type-2-&t=635263692022369363 July 7, 2015
http://news.bms.com/press-release/rd-news/us-fda-approves-farxiga-dapagliflozin-tablets-treatment-adult-patients-type-2-&t=635256032862460041 January 1, 2015
http://news.bms.com/press-release/rd-news/us-fda-approves-farxiga-dapagliflozin-tablets-treatment-adult-patients-type-2-&t=635263697165377016 January 1, 2015

Please log in to uncover the email addresses, access the 1,766 results for astrazeneca.com, filters and more.

Create a free account

Already have an account? Sign in

More information about astrazeneca.com

Language of the website: English

Main technologies used:

Find email addresses from any website

Search contact information of any website in one click.

When you visit a website, click on the icon to find the email addresses related to the website.